QIAGEN NV Forecast, price target & analysts
QIAGEN NV Target price 2025 - Analyst rating & recommendation
QIAGEN NV Classifications & Recommendation:
QIAGEN NV Price Target
| Target Price | $49.67 |
| Price | $39.57 |
| Potential |
25.53%
register free of charge
|
| Number of Estimates | 20 |
|
20 Analysts have issued a price target QIAGEN NV 2026 .
The average QIAGEN NV target price is $49.67.
This is
25.53%
register free of charge
$55.00
38.99%
register free of charge
$42.00
6.14%
register free of charge
|
|
| A rating was issued by 23 analysts: 13 Analysts recommend QIAGEN NV to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the QIAGEN NV stock has an average upside potential 2026 of
25.53%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.98 | 2.03 |
| 0.66% | 2.85% | |
| EBITDA Margin | 20.38% | 37.44% |
| 38.43% | 83.70% | |
| Net Margin | 4.15% | 21.17% |
| 75.95% | 409.93% |
21 Analysts have issued a sales forecast QIAGEN NV 2025 . The average QIAGEN NV sales estimate is
This results in the following potential growth metrics:
20 Analysts have issued an QIAGEN NV EBITDA forecast 2025. The average QIAGEN NV EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 QIAGEN NV Analysts have issued a net profit forecast 2025. The average QIAGEN NV net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.38 | 1.99 |
| 75.80% | 423.68% | |
| P/E | 19.86 | |
| EV/Sales | 4.35 |
12 Analysts have issued a QIAGEN NV forecast for earnings per share. The average QIAGEN NV <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the QIAGEN NV stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current QIAGEN NV Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Baird | Outperform ➜ Neutral | Downgrade | Feb 19 2025 |
| UBS | Neutral ➜ Neutral | Unchanged | Feb 07 2025 |
| Morgan Stanley | Overweight ➜ Equal-Weight | Downgrade | Jan 06 2025 |
| HSBC | Buy ➜ Hold | Downgrade | Oct 17 2024 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
Baird: Outperform ➜ Neutral
|
Feb 19 2025 |
|
Unchanged
UBS: Neutral ➜ Neutral
|
Feb 07 2025 |
|
Downgrade
Morgan Stanley: Overweight ➜ Equal-Weight
|
Jan 06 2025 |
|
Downgrade
HSBC: Buy ➜ Hold
|
Oct 17 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
